Mali launches HPV vaccine to save women from cervical cancer
Mali launches HPV vaccine to save women from cervical cancer
In a historic move, the Malian government has integrated the human papillomavirus (HPV) vaccine into its routine immunization program this November. During a launch ceremony in Bamako, attended by dignitaries and international partners, Gavi and the Ministry of Health and Social Development emphasized the significance of this initiative, marking a major leap in the fight against cervical cancer among Malian women.
The battle against cervical cancer in Mali has taken a decisive turn with the introduction of the HPV vaccine. This disease remains a tragic scourge for many Malian women, often diagnosed too late when treatment options are limited and costly.
Consider the story of Fatoumata, a 38-year-old woman whose life was upended by this illness. « I initially had a fibroid, and it took me time to address it, » she recalls. « It was only when I started experiencing bleeding that I decided to have surgery. After the operation, I noticed unusual discharge—colorless and odorless, like water. That’s when I visited my gynecologist, and the tests revealed cervical cancer. »
This groundbreaking initiative aims to shield over 320,000 young girls in Mali each year, potentially reducing cervical cancer cases by nearly 90%. It could prevent more than 3,600 deaths annually among Malian women.
Fatoumata’s story underscores the harsh realities faced by women in Mali, where late diagnoses and inaccessible treatments exacerbate the burden of this disease. Cultural taboos and misconceptions often silence women, delaying critical medical interventions.
The burden of cervical cancer in Mali
Cervical cancer, primarily caused by persistent HPV infection, is a pressing public health crisis in Mali. It ranks as the second most common cancer among women aged 15 to 44. Cultural myths and stigma, such as attributing the disease to curses or vengeful acts by rivals, further delay diagnosis and treatment. « Some believe cervical cancer is a curse cast by co-wives or former partners, » explains a reproductive health advocate.
A turning point: the HPV vaccine launch
Mali has made history by introducing the HPV vaccine into its routine immunization program. Dr. Ibrahima Diarra, Director of the National Immunization Center, highlighted the significance of this milestone during the Bamako launch event: « A single dose can protect a 10-year-old girl for over a decade against the viruses responsible for 70% of cervical cancers. » Thanks to support from Gavi and co-financing from the Malian government, the vaccine is now available free of charge to young girls.
With this initiative, Mali aims to protect over 320,000 girls annually, cutting cervical cancer cases by nearly 90% and potentially saving 3,600 lives each year.
Further reading
A step toward health equity
This vaccination program represents a significant stride toward health equity. Cervical cancer claims the lives of thousands of women daily, particularly in low-income countries. In 2022 alone, 348,000 deaths were reported worldwide, with 90% occurring in these nations. By introducing the HPV vaccine, Mali is ensuring equitable access to prevention, both in urban and rural areas.
Dr. Diarra explains the rationale behind targeting 10-year-old girls: « We chose this age group because their cervixes are still healthy, long before the onset of sexual activity, ensuring maximum vaccine efficacy. » This approach aligns with WHO recommendations to prioritize vaccination for girls aged 9 to 14.
Mali stands out as one of the first Sahelian nations and the first conflict-affected, fragile country supported by Gavi to introduce the HPV vaccine.
Preventing cervical cancer through the HPV vaccine also reduces the financial burden of treating the disease. « A single dose costs around 150,000 FCFA in private pharmacies, but thanks to Gavi’s support and government co-financing, the vaccine is now free as part of the routine immunization program, » Dr. Diarra notes.
This initiative not only safeguards generations of Malian women but also sets a powerful example for other countries in the region. It aligns with Gavi’s global goals to vaccinate 86 million girls in low- and middle-income countries by 2025.
Combating misinformation
Mali’s health authorities face a critical challenge: misinformation. Rumors and fake news about vaccines, fueled by opponents, threaten to undermine public trust. « It’s crucial to counter these false claims, » insists Dr. Diarra. « This vaccine is safe, effective, and does not compromise the fertility or reproductive health of young girls. »
During the launch, the Minister of Health, Colonel Assa Badiallo Touré, also reaffirmed the vaccine’s safety and importance.
The introduction of the HPV vaccine marks a pivotal victory for women’s health and a step toward a more equitable future in Mali. By breaking the cycle of disease through prevention, the country exemplifies a public health model centered on equity, protecting the most vulnerable and securing a safer future for Malian women.